Further investigations revealed that ANO1 amplification and overexpression are significantly correlated with tumor grade and poor prognosis, promoting tumor proliferation through the epidermal growth factor receptor (EGFR) and calmodulin-dependent protein kinase II (CAMKII) signaling pathways (27). This evidence concerns the gene ANO1 and neoplasm.